{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:27:20Z","timestamp":1783744040269,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:00:00Z","timestamp":1767484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017964","name":"Tianjin Municipal Health Commission","doi-asserted-by":"publisher","award":["TJYXZDXK-3-004D"],"award-info":[{"award-number":["TJYXZDXK-3-004D"]}],"id":[{"id":"10.13039\/100017964","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.vaccine.2025.128156","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T13:32:45Z","timestamp":1766842365000},"page":"128156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Characterization and vaccine-induced immunogenicity of a re-emerging Neisseria meningitidis serogroup Y in Tianjin, China"],"prefix":"10.1016","volume":"73","author":[{"given":"Guoping","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuwen","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangxu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.128156_bb0005","unstructured":"World Health Organization. Meningitis overview. Available at: https:\/\/www.who.int\/health-topics\/meningitis#tab=tab_1. Accessed 1 Aug 2025."},{"key":"10.1016\/j.vaccine.2025.128156_bb0010","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3201\/eid1904.111799","article-title":"Description and nomenclature of Neisseria meningitidis capsule locus","volume":"19","author":"Harrison","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128156_bb0015","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/14760584.2024.2329618","article-title":"The important lessons lurking in the history of meningococcal epidemiology","volume":"23","author":"Borrow","year":"2024","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.128156_bb0020","unstructured":"National Health Commission of the People's Republic of China. Circular on the Issuance of the National Immunization Program Vaccine Schedule for Children and Its Interpretation (2021 Edition).2021-02-23. https:\/\/www.nhc.gov.cn\/jkj\/c100063\/202103\/c37c8bf6f00f446c8fa84f3134ac2360.shtml."},{"key":"10.1016\/j.vaccine.2025.128156_bb0025","unstructured":"Zhou JJ, Li MS, Zhang Q, Yan TT, Wu D, Li YX, et al. Analysis on incidence trend of meningococcal meningitis and major pathogenic serogroups of Neisseria meningitidis in China, 1990-2023. Zhonghua Liu Xing Bing Xue Za Zhi 2024,45(9):1197\u20131203.https:\/\/rs.yiigle.com\/cmaid\/1515250."},{"key":"10.1016\/j.vaccine.2025.128156_bb0030","unstructured":"Guo LC, Liu XC, Xu QY, Yiu YS, Cai Y, Jiang GQ, et al. Epidemiological analysis on serogroup Y neisseria meningitidis firstly isolated from patient in Tianjin. Zhonghua Yu Fang Yi Xue Za Zhi 2016,50(9):825\u2013827.https:\/\/rs.yiigle.com\/cmaid\/907559."},{"issue":"11","key":"10.1016\/j.vaccine.2025.128156_bb0035","first-page":"1295","article-title":"Etiological characteristics of strains from cases of epidemic cerebrospinal meningitis due to newly isolated Neisseria meningitidis serogroups X and Y in Hunan Province","volume":"28","author":"Xia","year":"2021","journal-title":"Shi Yong Yu Fang Yi Xue"},{"key":"10.1016\/j.vaccine.2025.128156_bb0040","unstructured":"Wang SL, Huang YJ, Li DD, Wu QZ, Cai YG, Kuang SZ, et al. Epidemiology, molecular characteristics and antibiotic susceptibility analysis of Neisseria meningitidis serogroup Y in Hainan Province. China Trop Medicine 2024,24(10):1241\u20131245. doi: 10.13604\/j.cnki.46-1064\/r.2024.10.14."},{"issue":"4","key":"10.1016\/j.vaccine.2025.128156_bb0045","first-page":"454","article-title":"Etiological and epidemiological analysis of Neisseria meningitidis CC23 infection cases in group Y in Yulin city","volume":"40","author":"Qiu","year":"2025","journal-title":"Guangxi Zhuang Autonomous Region Disease Surveillance"},{"issue":"12","key":"10.1016\/j.vaccine.2025.128156_bb0050","doi-asserted-by":"crossref","first-page":"242","DOI":"10.46234\/ccdcw2024.048","article-title":"An outbreak of serogroup Y meningococcal meningitis in a private secondary vocational school - Guangzhou City, Guangdong Province, China, 2023","volume":"6","author":"Zeng","year":"2024","journal-title":"China CDC Wkly"},{"issue":"05","key":"10.1016\/j.vaccine.2025.128156_bb0055","first-page":"568","article-title":"Investigation and response for the first case of group Y meningococcal meningitis in Fujian province, 2024","volume":"30","author":"Hu","year":"2024","journal-title":"Chin J Vacc Immun"},{"issue":"47","key":"10.1016\/j.vaccine.2025.128156_bb0060","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.46234\/ccdcw2024.249","article-title":"The first case of serogroup Y Neisseria meningitidis and an expanded investigation of healthy carriers - Shijiazhuang City, Hebei Province, China, 2023","volume":"6","author":"Guo","year":"2024","journal-title":"China CDC Wkly"},{"issue":"02","key":"10.1016\/j.vaccine.2025.128156_bb0065","first-page":"165","article-title":"Investigation of the first case of group Y meningococcal meningitis in Guizhou province, 2023","volume":"30","author":"Rui","year":"2024","journal-title":"Chin J Vaccines Immun"},{"issue":"Pt2","key":"10.1016\/j.vaccine.2025.128156_bb0070","article-title":"Development and validation of a standardized human complement serum bactericidal activity assay to measure functional antibody responses to Neisseria gonorrhoeae","volume":"43","author":"Matthias","year":"2025","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2025.128156_bb0075","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.vaccine.2022.11.048","article-title":"A phase 3, randomized, controlled, open-label study to evaluate the persistence up to 5 years of 1 or 2 doses of meningococcal conjugate vaccine MenACWY-TT given with or without 13-valent pneumococcal conjugate vaccine in 12-14-month-old children","volume":"41","author":"Cutland","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128156_bb0080","series-title":"Correlates of vaccine-induced protection: Methods and implications","author":"World Health Organization","year":"2013"},{"issue":"7","key":"10.1016\/j.vaccine.2025.128156_bb0085","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3390\/vaccines13070724","article-title":"An evaluation of the safety, immunogenicity, and protective efficacy of a combined diphtheria-tetanus-acellular pertussis, haemophilus influenzae type b, and ACYW135 meningococcal conjugate vaccine in murine and rat models","volume":"13","author":"Sui","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2025.128156_bb0090","unstructured":"Chinese Pharmacopoeia Commission. Group a and group C meningococcal conjugate vaccine. In Chinese pharmacopoeia 3.5.4 potency assay; Chinese pharmacopoeia commission: Beijing, China, 2025. https:\/\/www.nmpa.gov.cn\/xxgk\/fgwj\/gzwj\/gzwjyp\/20250325183810122.html."},{"issue":"7","key":"10.1016\/j.vaccine.2025.128156_bb0095","first-page":"569","article-title":"Investigation of antibody level against Neisseria meningitidis W135 and Y in healthy population in Tianjin, 2016","volume":"33","author":"Luo","year":"2018","journal-title":"Disease Surveillance"},{"issue":"03","key":"10.1016\/j.vaccine.2025.128156_bb0100","first-page":"288","article-title":"Monitoring antibody levels of serogroup a, C, W135 and Y Neisseria meningitidis in a healthy population of Tianjin in 2017-2018 and 2020","volume":"28","author":"Guo","year":"2022","journal-title":"Chin J Vaccines Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2025.128156_bb0105","article-title":"Population-based surveillance of Neisseria meningitidis antimicrobial resistance in the United States. Open forum","volume":"2","author":"Harcourt","year":"2015","journal-title":"Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128156_bb0110","doi-asserted-by":"crossref","unstructured":"Mikucki A, Kahler CM. Microevolution and its impact on hypervirulence, antimicrobial resistance, and vaccine escape in Neisseria meningitidis. Microorganisms 2023;11(12):3005. https:\/\/www.mdpi.com\/2076-2607\/11\/12\/3005.","DOI":"10.3390\/microorganisms11123005"},{"key":"10.1016\/j.vaccine.2025.128156_bb0115","unstructured":"Xu L, Han FY, Wu D, Zhu BQ, Gao WY, Gao Y, et al. Analysis on antimicrobial sensitivity of Neisseria meningitidis in China from 2005 to 2019. Zhonghua Yu Fang Yi Xue Za Zhi 2021;55(2):207\u2013211.https:\/\/rs.yiigle.com\/cmaid\/1309162."},{"issue":"6","key":"10.1016\/j.vaccine.2025.128156_bb0120","first-page":"6","article-title":"Diagnosis and treatment protocol for meningococcal meningitis (2023 edition)","volume":"31","author":"National Health Commission of the People\u2019\u2019s Republic of China","year":"2024","journal-title":"Chin Pract J Rural Doctor"},{"issue":"19S1","key":"10.1016\/j.vaccine.2025.128156_bb0125","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.vaccine.2024.06.017","article-title":"The role of vaccines in reducing antimicrobial resistance: a review of potential impact of vaccines on AMR and insights across 16 vaccines and pathogens","volume":"42","author":"Hasso-Agopsowicz","year":"2024","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2025.128156_bb0130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4236\/wjv.2013.32012","article-title":"Proteoliposome and polysaccharide-based meningococcal vaccine are immunogenic in infants and toddlers and primes for memory against serogroup C polysaccharide","volume":"3","author":"P\u00e9rez","year":"2013","journal-title":"World J Vacc"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T09:05:09Z","timestamp":1770282309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25014549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":26,"alternative-id":["S0264410X25014549"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128156","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization and vaccine-induced immunogenicity of a re-emerging Neisseria meningitidis serogroup Y in Tianjin, China","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128156"}}